CN Patent

CN1678324A — 雌激素替代治疗方案

Assigned to Individual · Expires 2005-10-05 · 21y expired

What this patent protects

本发明提供向绝经期妇女传递雌激素的改进方法，其包括给药与正常剂量的雌二醇交替的超低剂量的雌二醇。

USPTO Abstract

本发明提供向绝经期妇女传递雌激素的改进方法，其包括给药与正常剂量的雌二醇交替的超低剂量的雌二醇。

Drugs covered by this patent

Estrace (ESTRADIOL) · Pfizer

Patent Metadata

Patent number: CN1678324A
Jurisdiction: CN
Classification: —
Expires: 2005-10-05
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.